DeutschNewstral
Article
wsj.com on 2016-11-10 14:48
Perrigo Considering Strategic Alternatives for MS Drug
Related news
NCR considering "strategic alternatives," including sale of the companybizjournals.com
Perrigo shareholders reject $26B bid from drug rival MylanThe Findlay Courier
Mylan makes official bid for Perrigo in generic drug contestdothaneagle.com
Generic drug maker Mylan makes official offer for PerrigoHaaretz
Yahoo to say it is exploring 'strategic alternatives'Reuters
Perrigo steps up effort vs. drug giant Mylan; Huntington Bank 2nd-largest SBA lenderpost-gazette.com- Enjoy Tech is considering 'strategic alternatives' as its cash dwindles and its stock dove nearly 53%bizjournals.com
WME owner Endeavor says it is considering ‘strategic alternatives’ amid stock slumpLA Times- BBed Bath & Beyond Misses Estimates. Considering 'All Strategic Alternatives' to Meet Goals.1 min readbarrons.com
- MBed Bath & Beyond CEO says troubled retailer considering ‘all strategic alternatives’2 min readmarketwatch.com
- Another Houston energy co. receives delisting warning, still considering strategic alternativesbizjournals.com
- Cabela's Exploring Strategic Alternativeswsj.com
- MVictoria's Secret parent L Brands stock soars on WSJ report that it's exploring strategic alternatives, Wexner to step downmarketwatch.com
- SunEdison yieldcos exploring strategic alternativesbizjournals.com
- SolarWinds to Explore Strategic Alternativeswsj.com
- Gevo to explore 'strategic alternatives'bizjournals.com
- Perrigo spurning Mylan’s advancepost-gazette.com
- Perrigo resists Mylan bidbizjournals.com
- Starboard Value Takes 4.6% Stake in Perrigowsj.com